Schrodinger, Inc. SEC filings SDGR
Schrodinger, Inc. has 539 filings in SEC EDGAR's recent list, going back to May 5, 2010. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 12, 2020 | — |
| CORRESP | Letter to the SEC | Aug 10, 2020 | — |
| CORRESP | Letter to the SEC | Aug 10, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2020 | — |
| DRS | Filing | Jul 31, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 7, 2020 | — |
| EFFECT | Filing | Feb 5, 2020 | — |
| CERT | Filing | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 3, 2020 | — |
| 8-A12B | Filing | Jan 31, 2020 | — |
| CORRESP | Letter to the SEC | Jan 16, 2020 | — |
| CORRESP | Letter to the SEC | Jan 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2019 | — |
| DRSLTR | Filing | Dec 13, 2019 | — |
| DRS/A | Filing | Dec 13, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2019 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2019 | — |
| DRS | Filing | Oct 30, 2019 | — |
| D/A | Filing | May 8, 2019 | — |
| D | Filing | Nov 14, 2018 | — |
| D | Filing | Jun 19, 2015 | — |
| D | Filing | Dec 17, 2012 | — |
| D | Filing | May 5, 2010 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SDGR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1490978
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.